InsightfulValue
← Home

Daiichi Sankyo
Daiichi Sankyo

-4.06%

Pharma / Pharmaceuticals, Biotechnology


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

Daiichi Sankyo

πŸ“Š Get full analytics about Daiichi Sankyo

Sign up for free or log in

πŸ‘₯ Free eBook for new users: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Price
Live  
Overview
and its operations
Daiichi Sankyo is a global pharmaceutical company based in Japan. It was founded in 2005 through the merger of two Japanese pharmaceutical companies, Daiichi Pharmaceutical and Sankyo Co., Ltd. The company's global headquarters is located in Tokyo, Japan, and it has several research and development sites in Japan, Germany, and the United States.
Daiichi Sankyo is primarily focused on the development of innovative medicines for the treatment of cardiovascular, metabolic, and infectious diseases, as well as oncology. The company also has a strong presence in the over-the-counter and generic drug markets.
Daiichi Sankyo operates in more than 20 countries worldwide and has a diverse portfolio of drugs marketed in over 60 countries. The company's global sales in the fiscal year 2020 were approximately 950 billion yen (about $8.8 billion USD).
In addition to developing and marketing drugs, Daiichi Sankyo is also actively engaged in research and development collaborations with academic institutions and other pharmaceutical companies. The company's goal is to continue expanding its portfolio and delivering innovative treatment options to patients around the world.
Some of Daiichi Sankyo's notable drugs include:
- LIXIANA (rivaroxaban), an oral anticoagulant used to prevent and treat blood clots
- Thromboreductin (tenecteplase), a clot-dissolving enzyme used to treat heart attacks
- EVISTA (raloxifene), a selective estrogen receptor modulator used to treat osteoporosis and reduce the risk of developing breast cancer
- RECLAST (zoledronic acid), an intravenous medication used to treat osteoporosis and prevent bone fractures
- Benicar (olmesartan medoxomil), a blood pressure medication used to treat hypertension
- Oncology drugs, including ENHERTU (trastuzumab deruxtecan), for the treatment of HER2-positive breast and gastric cancer, and pexidartinib, for the treatment of certain types of tumors.
What is special about the company?
Daiichi Sankyo

πŸ“ˆ Want to read more about Daiichi Sankyo?

Sign up for free or log in

πŸ™Œ Join now to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" at no cost

MS4gUGlvbm VlcmluZyBQ aGFybWFjZX V0aWNhbCBD b21wYW55Oi BEYWlpY2hp IFNhbmt5by BpcyBhIGds b2JhbCBwaG FybWFjZXV0 aWNhbCBjb2 1wYW55IHRo YXQgaGFzIG JlZW4gaW4g b3BlcmF0aW 9uIGZvciBv dmVyIDEwMC B5ZWFycy4g SXQgaGFzIG Egc3Ryb25n IHRyYWNrIH JlY29yZCBv ZiBkZXZlbG 9waW5nIGlu bm92YXRpdm UgbWVkaWNp bmVzIGFuZC B0cmVhdG1l bnRzIGZvci B2YXJpb3Vz IGRpc2Vhc2 VzIGFuZCBj b25kaXRpb2 5zLjxicj4y LiBHbG9iYW wgUHJlc2Vu Y2U6IFRoZS Bjb21wYW55 IGhhcyBhIH N0cm9uZyBp bnRlcm5hdG lvbmFsIHBy ZXNlbmNlLC B3aXRoIG9w ZXJhdGlvbn MgaW4gbW9y ZSB0aGFuID UwIGNvdW50 cmllcyB3b3 JsZHdpZGUu IEl0IGhhcy BhIHdpZGUg bmV0d29yay BvZiByZXNl YXJjaCwgZG V2ZWxvcG1l bnQsIGFuZC BtYW51ZmFj dHVyaW5nIG ZhY2lsaXRp ZXMgaW4gQX NpYSwgRXVy b3BlLCBhbm QgTm9ydGgg QW1lcmljYS 48YnI+My4g Rm9jdXNlZC BvbiBLZXkg VGhlcmFwZX V0aWMgQXJl YXM6IERhaW ljaGkgU2Fu a3lvIGlzIG ZvY3VzZWQg b24gZGV2ZW xvcGluZyB0 cmVhdG1lbn RzIGluIGEg ZmV3IGtleS B0aGVyYXBl dXRpYyBhcm VhcywgbmFt ZWx5IGNhcm Rpb3Zhc2N1 bGFyIGRpc2 Vhc2UsIG9u Y29sb2d5LC BwYWluIG1h bmFnZW1lbn QsIGFuZCBp bW11bmUgZG lzb3JkZXJz LiBUaGlzIG FsbG93cyB0 aGUgY29tcG FueSB0byBj b25jZW50cm F0ZSBpdHMg cmVzb3VyY2 VzIGFuZCBl eHBlcnRpc2 Ugb24gZGV2 ZWxvcGluZy BlZmZlY3Rp dmUgdHJlYX RtZW50cyBp biB0aGVzZS BhcmVhcy48 YnI+NC4gQ2 9tbWl0bWVu dCB0byBSZX NlYXJjaCBh bmQgRGV2ZW xvcG1lbnQ6 IFRoZSBjb2 1wYW55IGlu dmVzdHMgYS BzaWduaWZp Y2FudCBwb3 J0aW9uIG9m IGl0cyByZX ZlbnVlIGlu dG8gcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50LCB3 aXRoIGEgc3 Ryb25nIGZv Y3VzIG9uIG RldmVsb3Bp bmcgaW5ub3 ZhdGl2ZSB0 cmVhdG1lbn RzLiBUaGlz IGNvbW1pdG 1lbnQgdG8g UiZEIGhhcy BoZWxwZWQg dGhlbSB0by BicmluZyBt YW55IGxpZm Utc2F2aW5n IGFuZCBsaW ZlLWVuaGFu Y2luZyBtZW RpY2luZXMg dG8gcGF0aW VudHMgd29y bGR3aWRlLj xicj41LiBD b2xsYWJvcm F0aXZlIEFw cHJvYWNoOi BEYWlpY2hp IFNhbmt5by BlbWJyYWNl cyBhIGNvbG xhYm9yYXRp dmUgYXBwcm 9hY2ggdG8g cmVzZWFyY2 ggYW5kIGRl dmVsb3BtZW 50LCBwYXJ0 bmVyaW5nIH dpdGggb3Ro ZXIgY29tcG FuaWVzLCBy ZXNlYXJjaC BpbnN0aXR1 dGlvbnMsIG FuZCBhY2Fk ZW1pYyBjZW 50ZXJzIHRv IGJyaW5nIG l0cyBtZWRp Y2luZXMgdG 8gbWFya2V0 LiBUaGlzIG NvbGxhYm9y YXRpb24gaG VscHMgdG8g YWNjZWxlcm F0ZSB0aGUg ZGV2ZWxvcG 1lbnQgb2Yg bmV3IGRydW dzIGFuZCB0 cmVhdG1lbn RzLjxicj42 LiBTdHJvbm cgUGlwZWxp bmU6IFRoZS Bjb21wYW55 IGhhcyBhIH JvYnVzdCBw aXBlbGluZS BvZiBpbm5v dmF0aXZlIG 1lZGljaW5l cyBpbiB2YX Jpb3VzIHN0 YWdlcyBvZi BkZXZlbG9w bWVudCwgcH JvdmlkaW5n IGEgc3Ryb2 5nIGZvdW5k YXRpb24gZm 9yIGZ1dHVy ZSBncm93dG ggYW5kIGV4 cGFuc2lvbi 48YnI+Ny4g Q29ycG9yYX RlIFNvY2lh bCBSZXNwb2 5zaWJpbGl0 eTogRGFpaW NoaSBTYW5r eW8gaXMgY2 9tbWl0dGVk IHRvIGNvcn BvcmF0ZSBz b2NpYWwgcm VzcG9uc2li aWxpdHkgYW 5kIHN1c3Rh aW5hYmlsaX R5LCB3aXRo IGEgZm9jdX Mgb24gZXRo aWNhbCBidX NpbmVzcyBw cmFjdGljZX MsIGVtcGxv eWVlIHdlbG wtYmVpbmcs IGFuZCBzb2 NpYWwgYW5k IGVudmlyb2 5tZW50YWwg aW5pdGlhdG l2ZXMuPGJy PjguIFBhdG llbnQtQ2Vu dGVyZWQgQX Bwcm9hY2g6 IFRoZSBjb2 1wYW55J3Mg bWlzc2lvbi BpcyB0byBz dHJpdmUgZm 9yIHRoZSAi Y3JlYXRpb2 4gb2YgbmV3 IGhlYWx0aG NhcmUgZnJv bnRpZXJzIi B0aHJvdWdo IHRoZSBkZX ZlbG9wbWVu dCBvZiBpbm 5vdmF0aXZl IG1lZGljaW 5lcyB0aGF0 IG1lZXQgdG hlIG5lZWRz IGFuZCBpbX Byb3ZlIHRo ZSBxdWFsaX R5IG9mIGxp ZmUgb2YgcG F0aWVudHMg d29ybGR3aW RlLjxicj45 LiBEaXZlcn NpZmllZCBQ b3J0Zm9saW 86IEluIGFk ZGl0aW9uIH RvIGl0cyBw aGFybWFjZX V0aWNhbCBi dXNpbmVzcy wgRGFpaWNo aSBTYW5reW 8gYWxzbyBo YXMgYSBwcm VzZW5jZSBp biBvdGhlci BoZWFsdGhj YXJlIHNlY3 RvcnMsIGlu Y2x1ZGluZy BvdmVyLXRo ZS1jb3VudG VyIG1lZGlj YXRpb25zLC BtZWRpY2Fs IGRldmljZX MsIGFuZCBk aWFnbm9zdG ljcywgcHJv dmlkaW5nIG EgZGl2ZXJz aWZpZWQgcG 9ydGZvbGlv IG9mIHByb2 R1Y3RzIGFu ZCBzZXJ2aW Nlcy48YnI+ MTAuIFN0cm 9uZyBNYW5h Z2VtZW50IF RlYW06IFRo ZSBjb21wYW 55IGhhcyBh IHN0cm9uZy BhbmQgZXhw ZXJpZW5jZW QgbWFuYWdl bWVudCB0ZW FtIHdpdGgg YSBwcm92ZW 4gdHJhY2sg cmVjb3JkIG 9mIHN1Y2Nl c3MgaW4gdG hlIHBoYXJt YWNldXRpY2 FsIGluZHVz dHJ5LCBlbn N1cmluZyB0 aGUgY29tcG FueSdzIHN0 cm9uZyBwZX Jmb3JtYW5j ZSBhbmQgbG 9uZy10ZXJt IHN1c3RhaW 5hYmlsaXR5 Lg==
What the company's business model?
Daiichi Sankyo

πŸ“ˆ Want to read more about Daiichi Sankyo?

Sign up for free or log in

βœ… Download "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” totally free!

RGFpaWNoaS BTYW5reW8g aXMgYSBnbG 9iYWwgcGhh cm1hY2V1dG ljYWwgY29t cGFueSB0aG F0IGZvY3Vz ZXMgb24gdG hlIHJlc2Vh cmNoLCBkZX ZlbG9wbWVu dCwgYW5kIG 1hbnVmYWN0 dXJlIG9mIG lubm92YXRp dmUgbWVkaW NpbmVzLiBU aGVpciBidX NpbmVzcyBt b2RlbCByZX ZvbHZlcyBh cm91bmQgZG V2ZWxvcGlu ZyBhbmQgY2 9tbWVyY2lh bGl6aW5nIG 5ldyBhbmQg aW1wcm92ZW QgdHJlYXRt ZW50cyB0by BhZGRyZXNz IHVubWV0IG 1lZGljYWwg bmVlZHMuPG JyPlRoZSBj b21wYW55J3 MgY29yZSBi dXNpbmVzcy BzdHJhdGVn eSBpcyBidW lsdCBvbiB0 aHJlZSBrZX kgcGlsbGFy czogPGJyPj EuIElubm92 YXRpb246IE RhaWljaGkg U2Fua3lvIG ludmVzdHMg aGVhdmlseS BpbiByZXNl YXJjaCBhbm QgZGV2ZWxv cG1lbnQgKF ImRCkgdG8g ZGlzY292ZX IgYW5kIGRl dmVsb3Agbm V3IG1lZGlj aW5lcyBhY3 Jvc3MgYSBy YW5nZSBvZi B0aGVyYXBl dXRpYyBhcm VhcywgaW5j bHVkaW5nIG NhcmRpb3Zh c2N1bGFyLC BvbmNvbG9n eSwgYW5kIH JhcmUgZGlz ZWFzZXMuIF RoZSBjb21w YW55IGhhcy BhIGxhcmdl IGdsb2JhbC BSJkQgbmV0 d29yaywgaW 5jbHVkaW5n IHBhcnRuZX JzaGlwcyBh bmQgY29sbG Fib3JhdGlv bnMgd2l0aC BsZWFkaW5n IHVuaXZlcn NpdGllcyBh bmQgcmVzZW FyY2ggaW5z dGl0dXRpb2 5zLjxicj4y LiBHcm93dG g6IFRoZSBj b21wYW554o CZcyBncm93 dGggc3RyYX RlZ3kgaXMg Y2VudGVyZW Qgb24gZXhw YW5kaW5nIG l0cyBnbG9i YWwgcHJlc2 VuY2UgYW5k IHBvcnRmb2 xpbyB0aHJv dWdoIHN0cm F0ZWdpYyBw YXJ0bmVyc2 hpcHMsIGFs bGlhbmNlcy wgYW5kIGFj cXVpc2l0aW 9ucy4gVGhp cyBhbGxvd3 MgRGFpaWNo aSBTYW5reW 8gdG8gYWNj ZXNzIG5ldy BtYXJrZXRz LCB0ZWNobm 9sb2dpZXMs IGFuZCB0aG VyYXBpZXMs IGFzIHdlbG wgYXMgZGl2 ZXJzaWZ5IG l0cyBwcm9k dWN0IG9mZm VyaW5ncy48 YnI+My4gUm VzcG9uc2li aWxpdHk6IE RhaWljaGkg U2Fua3lvIG hhcyBhIHN0 cm9uZyBjb2 1taXRtZW50 IHRvIGV0aG ljYWwgYW5k IHNvY2lhbG x5IHJlc3Bv bnNpYmxlIG J1c2luZXNz IHByYWN0aW Nlcy4gVGhp cyBpbmNsdW RlcyBjb25k dWN0aW5nIG FsbCBidXNp bmVzcyBhY3 Rpdml0aWVz IHdpdGggaW 50ZWdyaXR5 IGFuZCB0cm Fuc3BhcmVu Y3ksIGFzIH dlbGwgYXMg c3VwcG9ydG luZyBpbml0 aWF0aXZlcy B0byBpbXBy b3ZlIGFjY2 VzcyB0byBo ZWFsdGhjYX JlIGFuZCBh ZGRyZXNzIG dsb2JhbCBo ZWFsdGggY2 hhbGxlbmdl cy48YnI+T3 ZlcmFsbCwg RGFpaWNoaS BTYW5reW8n cyBidXNpbm VzcyBtb2Rl bCBmb2N1c2 VzIG9uIGNv bnRpbnVhbG x5IGludmVz dGluZyBpbi BSJkQgYW5k IHN0cmF0ZW dpYyBncm93 dGggb3Bwb3 J0dW5pdGll cyB0byBkcm l2ZSBpbm5v dmF0aW9uIG FuZCBicmlu ZyBhZHZhbm NlZCBtZWRp Y2luZXMgdG 8gcGF0aWVu dHMgd29ybG R3aWRlLg==
Interesting facts about the company
Daiichi Sankyo

πŸ“ˆ Want to read more about Daiichi Sankyo?

Sign up for free or log in

✍️ Sign up to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" for free

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvZk pCNEZmczRM QUU1cG1TQ2 pkZ3Mud2Vi cCIgYWx0PS JEYWlpY2hp IFNhbmt5by IgdGl0bGU9 IkRhaWljaG kgU2Fua3lv IiAgY2xhc3 M9ImltZy1m bHVpZCIgaG VpZ2h0PTkw IHdpZHRoPT kwIGxvYWRp bmc9J2xhen knIHN0eWxl PSdib3JkZX ItcmFkaXVz OiA2cHg7Jz 4KCiAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nZmxl eDogMTsgdG V4dC1hbGln bjogY2VudG VyOyBtYXJn aW4tbGVmdD ogNXB4Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxwIHN0 eWxlPSdmb2 50LXNpemU6 IDI2cHg7IG NvbG9yOiAj MzMzOyBtYX JnaW4tYm90 dG9tOiAxNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICDwn5OI IFdhbnQgdG 8gcmVhZCBt b3JlIGFib3 V0IERhaWlj aGkgU2Fua3 lvPwogICAg ICAgICAgIC AgICAgICAg ICAgICA8L3 A+CgogICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdp bmRleC5waH A/cGFnZT1z aWdudXAnIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJh Y2tncm91bm QtY29sb3I6 ICMwMDdCRk Y7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bjb2xvcjog I2ZmZjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHBhZG Rpbmc6IDEw cHggMjBweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JvcmRlci1y YWRpdXM6ID VweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGZvbnQtd2 VpZ2h0OiBi b2xkOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbWFyZ2 luLXJpZ2h0 OiAxMHB4Ow ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdH JhbnNpdGlv bjogYmFja2 dyb3VuZC1j b2xvciAwLj NzIGVhc2U7 JwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg b25tb3VzZW 92ZXI9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA1 NmIzIicKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIG9ubW 91c2VvdXQ9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA3QkZGIi c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IGZvciBmcm VlCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxzcG FuIHN0eWxl PSdtYXJnaW 46IDAgOHB4 OyBjb2xvcj ogIzU1NTsn Pm9yPC9zcG FuPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPG EgaHJlZj0n aW5kZXgucG hwP3BhZ2U9 bG9naW4nIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGNv bG9yOiAjMD A3QkZGOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdGV4 dC1kZWNvcm F0aW9uOiB1 bmRlcmxpbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogNT AwOyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBsb2cg aW4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9h PgoKCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxw IHN0eWxlPS dtYXJnaW4t dG9wOiAxNX B4OyBmb250 LXNpemU6ID EzcHg7IGZv bnQtd2VpZ2 h0OiBib2xk OyBjb2xvcj ogI2QzMmYy ZjsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAg8J+TnS BKb2luIHVz IGFuZCBncm FiIHlvdXIg Y29weSBvZi A8aT4iVGhl IENoZWNrbG lzdCBWYWx1 ZSBJbnZlc3 RvciDigJQg QSBTbWFydG VyIFdheSB0 byBQaWNrIF N0b2NrcyI8 L2k+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv cD4KCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDwh LS0KICAgIC AgICAgICAg ICAgICAgIC AgICAgPGRp diBzdHlsZT 0nbWFyZ2lu LXRvcDogMT JweDsgZm9u dC1zaXplOi AxM3B4OyBj b2xvcjogIz Q0NDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgU2ln biB1cCBub3 cgYW5kIGdl dCBvdXIgZn JlZSBlQm9v ayAKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IDxiPlRoZS BDaGVja2xp c3QgVmFsdW UgSW52ZXN0 b3Ig4oCUIE EgU21hcnRl ciBXYXkgdG 8gUGljayBT dG9ja3M8L2 I+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AgICAgICAg ICAgICAtLT 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPCEtLQ ogICAgICAg ICAgICAgIC AgICAgICAg ICA8ZGl2IH N0eWxlPSdt YXJnaW4tdG 9wOiAxNnB4 OyBmb250LX NpemU6IDE0 cHg7IGNvbG 9yOiAjNDQ0 OyBmb250LW ZhbWlseTog LWFwcGxlLX N5c3RlbSwg QmxpbmtNYW NTeXN0ZW1G b250LCBTZW dvZSBVSSwg Um9ib3RvLC BIZWx2ZXRp Y2EgTmV1ZS wgc2Fucy1z ZXJpZjsgbG luZS1oZWln aHQ6IDEuNj snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgSGF2ZSB5 b3UgaGVhcm QgYWJvdXQg b3VyIHNob3 J0IDxzdHJv bmcgc3R5bG U9J2ZvbnQt d2VpZ2h0Oi A2MDA7Jz5E YWlseSBWaW RlbyBOZXdz bGV0dGVyPC 9zdHJvbmc+ PwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg PGEgaHJlZj 0naHR0cHM6 Ly93d3cuaW 5zaWdodGZ1 bHZhbHVlLm NvbS9uZXdz bGV0dGVyLn BocCcgdGFy Z2V0PSdfYm xhbmsnIHN0 eWxlPSdjb2 xvcjogIzAw N0JGRjsgdG V4dC1kZWNv cmF0aW9uOi Bub25lOyBm b250LXdlaW dodDogNTAw OyBtYXJnaW 4tbGVmdDog NnB4Oyc+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgRmluZCBv dXQgbW9yZQ ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgPC 9hPgogICAg ICAgICAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgICAgICAg ICAgICAgLS 0+CiAgICAg ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgICAgIC A8L2Rpdj4K ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg IAogICAgIC AgIAogICAg ICAgIDxzcG FuIGNsYXNz PSdibHVycm VkLXRleHQn PgogICAgIC AgICAgICBN UzRnUkdGcG FXIE5vYVNC VFlXNXIgZV c4Z1EyOXRj RyBGdWVTd2 dUR2x0IGFY UmxaQ0JwY3 kgQmhJR2Rz YjJKaCBiQ0 J3YUdGeWJX IEZqWlhWMG FXTmggYkNC amIyMXdZVy A1NUlIZHBk R2dnIGFYUn pJR2hsWVcg UnhkV0Z5ZE dWeSBjeUJz YjJOaGRHIF ZrSUdsdUlG UnYgYTNsdk xDQktZWCBC aGJpNGdTWF FnIGQyRnpJ R1p2ZFcgNW taV1FnYVc0 ZyBNakF3Tl NCMGFIIEp2 ZFdkb0lIUm 8gWlNCdFpY Sm5aWCBJZ2 IyWWdkSGR2 IElFcGhjR0 Z1WlggTmxJ SEJvWVhKdC BZV05sZFhS cFkyIEZzSU dOdmJYQmgg Ym1sbGN5d2 dSRyBGcGFX Tm9hU0JRIG FHRnliV0Zq WlggVjBhV0 5oYkNCaCBi bVFnVTJGdW EzIGx2SUVO dkxpd2cgVE hSa0xqeGlj aiA0eUxpQl VhR1VnIGJt RnRaU0JFWV cgbHBZMmhw SUZOaCBibX Q1YnlCMGNt IEZ1YzJ4aG RHVnogSUhS dklIUm9aUy BCbWFYSnpk Q0IwIGFISm xaU0IyYVgg SjBkV1Z6SU dsdSBJRVZ1 WjJ4cGMyIG dzSUhkb2FX Tm8gSUhONW JXSnZiRyBs NlpYTWdkR2 hsIElHTnZi WEJoYm4gbm lnSmx6SUdO diBiVzFwZE cxbGJuIFFn ZEc4Z1oyOX YgWkNCb1pX RnNkRyBnc0 lHbHVibTky IFlYUnBkbV VnYVcgUmxZ WE1zSUdGdS BaQ0J6YjJO cFlXIHdnWT I5dWMyTnAg YjNWemJtVn pjeSA0OFlu SStNeTRnIF JHRnBhV05v YVMgQlRZVz VyZVc4ZyBh R0Z6SUdFZ1 pHIGwyWlhK elpTQncgYj NKMFptOXNh VyA4Z2IyWW djSEpsIGMy TnlhWEIwYV cgOXVJRzFs WkdsaiBhVz VsY3l3Z1pt IDlqZFhOcG JtY2cgYjI0 Z1lYSmxZWC BNZ2MzVmph Q0JoIGN5Qm pZWEprYVcg OTJZWE5qZF d4aCBjaXdn YjI1amIyIH h2WjNrc0lH RnUgWkNCd1 lXbHVJRyAx aGJtRm5aVz FsIGJuUXVJ RlJvWlgga2 dZWEpsSUdG cyBjMjhnYV c1MmIyIHgy WldRZ2FXNG cgZEdobElH UmxkbSBWc2 IzQnRaVzUw IElHOW1JSF poWTIgTnBi bVZ6SUdGdS BaQ0JpYVc5 c2IyIGRwWT NNdVBHSnkg UGpRdUlFUm hhVyBsamFH a2dVMkZ1IG EzbHZJR2ho Y3kgQmhJSE 4wY205dSBa eUJ3Y21Wel pXIDVqWlNC cGJpQkIgYz JsaExDQjNh WCBSb0lHOT JaWElnIE1q WWxJRzltSU cgbDBjeUJ6 WVd4bCBjeU JqYjIxcGJt IGNnWm5Kdm JTQjAgYUds eklISmxaMi BsdmJpNGdT WFFnIFlXeH pieUJvWVgg TWdiM0JsY2 1GMCBhVzl1 Y3lCcGJpIE JPYjNKMGFD QkIgYldWeW FXTmhMQyBC RmRYSnZjR1 VzIElHRnVa Q0J2ZEcgaG xjaUJ3WVhK MCBjeUJ2Wm lCMGFHIFVn ZDI5eWJHUX UgUEdKeVBq VXVJRSBsdU lESXdNRFlz IElFUmhhV2 xqYUcga2dV MkZ1YTNsdi BJR0ZqY1hW cGNtIFZrSU dFZ2JXRnEg YjNKcGRIa2 djMyBSaGEy VWdLRFkwIE pTa2dhVzRn U1cgNWthV0 Z1SUdkbCBi bVZ5YVdNZ2 NHIGhoY20x aFkyVjEgZE dsallXd2dZ MiA5dGNHRn VlU0JTIFlX NWlZWGg1SU UgeGhZbTl5 WVhSdiBjbW xsY3k0Z1ZH IGhsSUdGam NYVnAgYzJs MGFXOXVJRy BGc2JHOTNa V1FnIFJHRn BhV05vYVMg QlRZVzVyZV c4ZyBkRzhn Wlhod1lXID VrSUdsMGN5 QnkgWldGam FDQnBiaSBC bGJXVnlaMm x1IFp5QnRZ WEpyWlggUn pManhpY2o0 MiBMaUJVYU dVZ1kyIDl0 Y0dGdWVTQn AgY3lCamIy MXRhWCBSMF pXUWdkRzhn IGMzVnpkR0 ZwYm0gRmlh V3hwZEhrZy BZVzVrSUdo aGN5IEJwYl hCc1pXMWwg Ym5SbFpDQj JZWCBKcGIz VnpJR2x1IG FYUnBZWFJw ZG0gVnpJSF J2SUhKbCBa SFZqWlNCcG RIIE1nWlc1 MmFYSnYgYm 0xbGJuUmhi QyBCcGJYQm hZM1FzIElI TjFZMmdnWV ggTWdjbVZr ZFdOcCBibW NnWTJGeVlt IDl1SUdWdG FYTnogYVc5 dWN5QmhibS BRZ2NISnZi VzkwIGFXNW 5JR2R5Wlcg VnVJSEJ5Yj JOMSBjbVZ0 Wlc1MExqIH hpY2o0M0xp QkUgWVdscF kyaHBJRiBO aGJtdDVieU JvIFlYTWdZ U0J6ZEggSn ZibWNnWm05 aiBkWE1nYj I0Z2NtIFZ6 WldGeVkyZ2 cgWVc1a0lH UmxkbSBWc2 IzQnRaVzUw IElDaFNKa1 FwTEMgQjNh WFJvSUc5Mi BaWElnWVNC eGRXIEZ5ZE dWeUlHOW0g SUdsMGN5Qm xiWCBCc2Iz bGxaWE1nIF pHVmthV05o ZEcgVmtJSF J2SUhSbyBh WE1nWVhKbF lTIDRnVkdo bGVTQm8gWV habElGSW1S QyBCbVlXTn BiR2wwIGFX VnpJR2x1SU UgcGhjR0Z1 TENCSCBaWE p0WVc1NUxD IEJoYm1RZ2 RHaGwgSUZW dWFYUmxaQy BCVGRHRjBa WE1zIElHRn RiMjVuSUcg OTBhR1Z5SU dOdiBkVzUw Y21sbGN5ID Q4WW5JK09D NGcgU1c0Z0 1qQXhNeSB3 Z1JHRnBhV0 5vIGFTQlRZ VzVyZVcgOG djbVZqWlds MiBaV1FnWV hCd2NtIDky WVd3Z1ptOX kgSUdsMGN5 Qm1hWCBKem RDQmhiblJw IFltOWtlUz FrY24gVm5J R052Ym1wMS BaMkYwWlNB b1FVIFJES1 NCd2NtOWsg ZFdOMExDQj NhRyBsamFD QmpiMjFpIG FXNWxjeUJo YmkgQmhibl JwWW05ayBl U0JoYm1RZ1 lTIEJqYUdW dGIzUm8gWl hKaGNIa2da SCBKMVp5Qj BieUIwIFlY Sm5aWFJsWk MgQmpZVzVq WlhJZyBZMl ZzYkhNZ1lX IDVrSUcxcG JtbHQgYVhw bElHUmhiVy BGblpTQjBi eUJvIFpXRn NkR2g1SUcg TmxiR3h6TG p4aSBjajQ1 TGlCVWFHIF VnWTI5dGNH RnUgZVNCb1 lYTWdZUyBC emRISnZibW NnIFkyOXRi V2wwYlcgVn VkQ0IwYnlC dyBhR2xzWV c1MGFIIEp2 Y0hrZ1lXNW sgSUdoaGN5 QnpaWCBRZ2 RYQWdkR2hs IElFUmhhV2 xqYUcga2dV MkZ1YTNsdi BJRVp2ZFc1 a1lYIFJwYj I0Z2IyWWcg VEdsbVpTQl RZMiBsbGJt TmxJSFJ2IE lITjFjSEJ2 Y24gUWdjbV Z6WldGeSBZ MmdnWVc1a0 lHIFZrZFdO aGRHbHYgYm lCcGJpQjBh RyBVZ2JHbG 1aU0J6IFky bGxibU5sY3 kgQm1hV1Zz WkM0OCBZbk krTVRBdUlF IEZ6SUc5bU lESXcgTWpF c0lFUmhhVy BsamFHa2dV MkZ1IGEzbH ZJR2hoWkMg QnZkbVZ5SU RFMiBMREF3 TUNCbGJYIE JzYjNsbFpY TWcgZDI5eW JHUjNhVyBS bElHRnVaQ0 JuIFpXNWxj bUYwWlcgUW diM1psY2lB ayBPQ0JpYV d4c2FXIDl1 SUdsdUlISm wgZG1WdWRX VXVJRSBsME lHbHpJSEpo IGJtdGxaQ0 JoYlcgOXVa eUIwYUdVZy BkRzl3SURJ d0lIIEJvWV hKdFlXTmwg ZFhScFkyRn NJRyBOdmJY QmhibWxsIG N5Qm5iRzlp WVcgeHNlUz Q9CiAgICAg ICAgPC9zcG FuPgogICAg ICAgIAogIC AgICAgIA==
See Company Q&A
Daiichi Sankyo

πŸ“Š Get full analytics about Daiichi Sankyo

Sign up for free or log in

πŸ†“ Discover "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" β€” free eBook!

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal